Literature DB >> 29473607

Simultaneous PML-IRIS and myelitis in a patient with neuromyelitis optica spectrum disorder.

Eoin P Flanagan1, Allen J Aksamit1, Neeraj Kumar1, Neha P Morparia1, B Mark Keegan1, Brian G Weinshenker1.   

Abstract

Entities:  

Year:  2013        PMID： 29473607      PMCID： PMC5765831          DOI： 10.1212/CPJ.0b013e3182a78f82

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  7 in total

1.  Progressive multifocal leukoencephalopathy in a patient with X-linked agammaglobulinemia.

Authors:  Takahide Teramoto; Hideo Kaneko; Michinori Funato; Hirofumi Sawa; Kazuo Nagashima; Yoshinobu Hirose; Naomi Kondo
Journal:  Scand J Infect Dis       Date:  2003

Review 2.  Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.

Authors:  Chen S Tan; Igor J Koralnik
Journal:  Lancet Neurol       Date:  2010-04       Impact factor: 44.182

Review 3.  Progressive multifocal leukoencephalopathy: a review of the neuroimaging features and differential diagnosis.

Authors:  M A Sahraian; E-W Radue; A Eshaghi; S Besliu; A Minagar
Journal:  Eur J Neurol       Date:  2011-12-05       Impact factor: 6.089

4.  Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside.

Authors:  A J Aksamit
Journal:  J Neurovirol       Date:  2001-08       Impact factor: 2.643

5.  Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases.

Authors:  Eamonn S Molloy; Leonard H Calabrese
Journal:  Arthritis Rheum       Date:  2009-12

Review 6.  The spectrum of neuromyelitis optica.

Authors:  Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

7.  Progressive multifocal leukoencephalopathy showing extensive spinal cord involvement in a patient with lymphocytopenia.

Authors:  Shigeki Takeda; Kazunori Yamazaki; Teruo Miyakawa; Hitoshi Takahashi; Fusahiro Ikuta; Hiroyuki Arai
Journal:  Neuropathology       Date:  2008-11-19       Impact factor: 1.906
  7 in total
  1 in total

Review 1.  Adverse Events in NMOSD Therapy.

Authors:  Katrin Giglhuber; Achim Berthele
Journal:  Int J Mol Sci       Date:  2022-04-09       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.